Trade MerckCo USA ^MRK

Merck & Co., Inc. (NYSE:MRK) Releases Earnings Results

Merck & Co., Inc. Q3 2026 Earnings Call Summary

Merck & Co., Inc. (MRK) Stock: Jumps 3.84% as Q3 2026 Revenue Rises 5% to $18.1 Billion

Merck Reports Q3 Revenue of $18.1 Billion, Raises 2026 Earnings Guidance

Merck 3Q Revenue Up on Keytruda, Winrevair Growth - Update | Morningstar

Merck Boosts FY26 Outlook - Update

Merck 3Q Revenue Up on Keytruda, Winrevair Growth | Morningstar

Merck & Co Inc. Q3 Income Retreats

17,813 Merck & Co., Inc. $MRK Shares Sold by D.A. Davidson & CO.

Merck & Co., Inc. $MRK Shares Sold by Convergence Financial LLC

12,469 Merck & Co., Inc. $MRK Shares Sold by Bokf Na

Health Sciences Authority of Singapore approves MSD's CAPVAXIVE pneumococcal 21-valent conjugate vaccine for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults

5-year outcomes of chemotherapy de-escalation in HER2-positive early breast cancer and exploratory circulating tumor DNA analyses from the randomized phase 2 PHERGain trial

Merck News | Markets Insider

Top Pharmaceutical Stocks To Follow Now - October 28th - Zolmax

13,296 Shares in Moderna, Inc. $MRNA Bought by Great Lakes Retirement Inc.

Merck & Co., Inc. $MRK Stock Purchased by DMC Group LLC - Markets Daily

Generali Asset Management SPA SGR Purchases 17,772 Shares of Merck & Co., Inc. $MRK - Stock Observer

Pharmaceutical Stocks To Research - October 27th - Zolmax

Moderna, Inc. (NASDAQ:MRNA) Stock Has Average Price Target of $101.45 - Markets Daily

FY2028 EPS Estimate for Moderna Cut by Analyst - Zolmax

Robeco Institutional Asset Management B.V. Makes New Investment in Moderna, Inc. $MRNA

New Indication Application for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Accepted for Review by NMPA

Merck & Co., Inc. $MRK Position Lifted by Oppenheimer & Co. Inc.

Leo Wealth LLC Makes New Investment in Merck & Co., Inc. $MRK

23,115 Merck & Co., Inc. $MRK Shares Sold by apricus wealth LLC

Merck & Co., Inc. $MRK Stock: Oppenheimer & Co. Inc. Boosts Stake - Daily Political

FY2028 EPS Forecast for Moderna Lowered by Analyst - Daily Political

FY2030 EPS Estimate for Moderna Lowered by Analyst - Zolmax

Merck's KEYTRUDA Cuts Progression Risk By 43% In Phase 3 Endometrial Cancer Trial

Wall Street Analysts Are Bullish on Top Healthcare Picks

Barclays Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price

Best Healthcare Stocks To Watch Today - October 26th - Stock Observer

Merck & Co., Inc. (NYSE:MRK) Stock Gets Price Target Increase from Barclays - Stock Observer

Apollon Wealth Management LLC Purchases 46,936 Shares of Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Holdings Lessened by Sigma Planning Corp - Daily Political

Barclays Reaffirms Their Buy Rating on Merck & Company (MRK)

Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Merck & Company (MRK)

Merck & Co., Inc. $MRK Stake Boosted by Norris Perne & French LLP MI - Markets Daily

The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine

Merck & Co., Inc. $MRK Stock: Valley National Advisers Inc. Lowers Holdings

Merck & Co., Inc. $MRK Position Trimmed by Middleton & Co. Inc. MA

Merck & Co., Inc. $MRK Stock: Mondrian Investment Partners LTD Cuts Holdings

Merck & Co., Inc. $MRK Stock Sold by Carolina Wealth Advisors LLC

Merck & Co., Inc. $MRK Stock Bought by Norris Perne & French LLP MI - Stock Observer

Evergreen Capital Management LLC Sells 69,731 Shares of Merck & Co., Inc. $MRK

BG Investment Services LLC Makes New $5.39 Million Investment in Merck & Co., Inc. $MRK

17,497 Merck & Co., Inc. $MRK Shares Acquired by Bernardo Wealth Planning LLC

Merck & Co., Inc. $MRK Holdings Decreased by Sterling Capital Management LLC - Stock Observer

Phase II Results of Sacituzumab Tirumotecan (sac-TMT) plus Pembrolizumab in Advanced Urothelial Carcinoma Presented at 2026 ESMO

Merck & Co., Inc. $MRK Stock Sold by Capital Investment Advisors LLC

Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial

Interpath-100: data leak, stock drop, spirited defense by ESMO president

Merck & Co., Inc. $MRK Stock: Investment House LLC Reduces Position

Ophthalmology Sector Emerges as Must-Win Battleground for Global Pharma: Eli Lilly, Merck & Co., AbbVie, Innovent Biologics, Hengrui Medicine and Leading Players Enter the Market

Moderna, Inc. (NASDAQ:MRNA) Stock Has Consensus Target Price of $101.45 According to Analysts - Stock Observer

Oncologists cheer melanoma data that tanked Moderna's shares | News & Features | ArcaMax Publishing

Moderna, Merck shares fall on eagerly anticipated cancer vaccine results

Moderna, Merck Shares Fall After Possible Melanoma Data Leak

6,761 Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas

Top Pharmaceutical Stocks To Add to Your Watchlist - October 22nd - Daily Political

Merck & Co., Inc. $MRK Stock Sold by Inlet Private Wealth LLC

Merck & Co., Inc. $MRK Stock Sold by Crossmark Global Holdings Inc.

Merck & Co., Inc. $MRK Shares Purchased by Diversify Advisory Services LLC

Merck & Co., Inc. (MRK) Set to Release Earnings on Thursday

Merck & Co., Inc. $MRK Stock Holdings Lowered by Cantor Fitzgerald Investment Advisors L.P.

27,739 Merck & Co., Inc. $MRK Shares Sold by Axxcess Wealth Management LLC

Merck & Co., Inc. $MRK Stock Sold by Smith Chas P & Associates PA Cpas - Daily Political

Small Cell Lung Cancer Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and Route of Administration Trends | AbbVie, Xcovery, Sanofi, Pfizer, Mirati Therapeutics, AstraZeneca | ABNewswire

Merck & Co., Inc. $MRK Stock Sold by Robeco Institutional Asset Management B.V.

Merck & Co., Inc. (NYSE:MRK) Cut to "Strong Sell" at Zacks Research

6,860 Merck & Co., Inc. $MRK Shares Sold by QV Investors Inc.

Merck & Co., Inc. $MRK Stock Sold by Nisa Investment Advisors LLC

119,254 Merck & Co., Inc. $MRK Shares Sold by Robeco Institutional Asset Management B.V. - Stock Observer

Bank Pictet & Cie Europe AG Sells 42,242 Shares of Merck & Co., Inc. $MRK

Merck & Co., Inc. (NYSE:MRK) Rating Lowered to Strong Sell at Zacks Research - Stock Observer

Merck & Co., Inc. (NYSE:MRK) Stock Rating Cut to Strong Sell at Zacks Research - Stock Observer

RBC Capital Reaffirms Their Hold Rating on Sanofi (SNYNF)

RBC Capital Remains a Buy on Eli Lilly & Co (LLY)

Dow leads Wall Street higher, investors focus on healthcare stocks

Merck & Co., Inc. $MRK Stock: Willis Investment Counsel Cuts Holdings

74,700 Merck & Co., Inc. $MRK Shares Sold by Willis Investment Counsel - Stock Observer

64,996 Merck & Co., Inc. $MRK Shares Sold by Sumitomo Mitsui DS Asset Management Company Ltd - Daily Political

RBC Capital Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

AbbVie (ABBV) Receives a Buy from RBC Capital

Merck & Co., Inc. $MRK Position Boosted by Fairvoy Private Wealth LLC

How Investors Are Reacting To Merck (MRK) Phase 3 Melanoma Results

Merck & Co., Inc. $MRK Stock Sold by BDF Gestion - Markets Daily

Merck & Co., Inc. $MRK Stock: BDF Gestion Decreases Holdings - Zolmax

13,487 Merck & Co., Inc. $MRK Shares Sold by Generali Investments Management Co LLC

Best Healthcare Stocks To Keep An Eye On - October 18th - Stock Observer

Merck & Co., Inc. $MRK Stock: Birch Hill Investment Advisors LLC Cuts Holdings

Merck & Co., Inc. $MRK Stock: 1834 Investment Advisors Co. Decreases Position

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Week ahead: Eurozone inflation, Fed meeting, Apple earnings

Week ahead: Wall Street’s Magnificent Seven earnings are up

Week ahead: Fed, BoE to hold; Apple leads big tech earnings

Moderna share price jumps as Oppenheimer upgrades stock

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk